Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Can High Tide’s Remexian acquisition turn it into a global cannabis leader? €26.4m deal explained High Tide acquires 51% of Germany's Remexian Pharma for €26.4M with a 5-year full buyout option. Find out how this move expands its global cannabis reach. byPallavi MadhirajuSeptember 2, 2025